Recently, in a consensus meeting, 16 expert authors attempted to make recommendations regarding the standardization of multiparametric MRI for detecting, localizing, and characterizing prostate cancer. The agreement rate was relatively low (approximately 60%) for defining the criteria, which mainly concerned conducting, interpreting, and reporting MRIs in patients with prostate cancer (18) . This shows that determining such criteria is extremely difficult. Nevertheless, similar studies are needed for prostate cancer staging.
T2-weighted MRI
Conventional T2-weighted sequences were the first MRI techniques to localize and stage prostate cancer and are still the most widely used imaging sequences. Prostate zonal anatomy and prostate cancer are best observed on multiplanar T2-weighted MRI. Furthermore, the prostatic capsule appears as a thin rim of low signal intensity surrounding the peripheral zone, and the seminal vesicles, which demonstrate high signal intensity because of their fluid content, are best evaluated anatomically on T2-weighted MRI. Lymphadenopathy can also be demonstrated easily by T2-weighted imaging. Hence, thin-section, high-spatial resolution fast spin-echo T2-weighted images in the axial, sagittal, and coronal planes are the main sequences for the local staging of prostate cancer with MRI.
Extracapsular extension with T2-weighted MRI
In previous studies, the reported sensitivities and specificities of MRI for the detection of extracapsular extension were in the range of 29%-80% and 47%-100%, respectively (19) (20) (21) (22) (23) . Patients with a tumor volume larger than 0.3 cm 3 are at a high risk of developing extracapsular extension (24) . Criteria for detecting extracapsular extension on T2-weighted MRI include at least one of the following: irregular capsular bulge, disruption of the prostatic capsule, extension into the periprostatic fat, broad contact with the capsule (>12 mm), obliteration of the rectoprostatic angle, or asymmetry or involvement of the neurovascular bundles (Figs. 1 and 2) (25, 26) . Multivariate analysis has shown that obliteration of the rectoprostatic angle and asymmetry of the neurovascular bundle are the strongest predictive factors for extracapsular extension (25) . Tempany et al. (27) reported that the sensitivity, specificity, and overall accuracy of T2-weighted MRI for neurovascular bundle invasion were 68%, 59%, and 64%, respectively.
Seminal vesicle invasion with T2-weighted MRI
In previous studies, sensitivity and specificity levels for diagnosing seminal vesicle invasion with MRI were in the range of 22%-77% and 80%-99%, respectively (19) (20) (21) (22) 28) . The main diagnostic criteria for seminal vesicle invasion on T2-weighted MRI are the lack of normal seminal vesicle architecture, focal or diffuse areas of low signal intensity within the seminal vesicle, low signal intensity within the seminal vesicle causing mass effect, enlarged ejaculatory ducts with low signal intensity, thickening of the ductus deferens, obliteration of the angle between the prostate and seminal vesicle on sagittal images, direct extension of the low signal intensity of tumor from the base of the prostate to the seminal vesicle, and non-contiguous areas of low signal intensity within the seminal vesicle (20, 29) . Low signal intensity within the seminal vesicle and lack of preservation of the normal architecture of the seminal vesicle have shown the highest sensitivity and specificity with T2-weighted MRI (Fig. 3) (20) . The presence of hemorrhage after biopsy can also result in low signal intensity within the seminal vesicle. Therefore, it is critical to combine the pre-contrast T1-weighted images with T2-weighted images in the evaluation of seminal vesicle invasion. In hemorrhage, the lower signal intensity of the seminal vesicle wall and the architecture of the seminal vesicle are preserved (20) . Additionally, inflammation, amyloidosis, atrophy, or inadequate distention of the seminal vesicles may cause wall thickening and complicate the evaluation for tumor invasion by prostate cancer.
Lymph node metastasis with T2-weighted MRI
In previous studies, MRI has been shown to have a low sensitivity (27%-60%) for the detection of lymph node metastasis, although it has a high specificity (98%) and negative prediction of extracapsular extension, seminal vesicle invasion, and lymph node metastasis. Additionally, intermediate and high-risk patients have been reported to derive the greatest benefit from MRI (10).
Staging with MRI
MRI is generally considered to be the most accurate imaging method for the local staging of prostate cancer (11) . However, when used for prostate cancer staging, MRI has a wide range of accuracy, sensitivity, and specificity values. Differences in patient selection, study protocols, MR equipment, type of coil, reader experience in prostate MRI, and a lack of standard diagnostic criteria for staging may explain the wide range of these values (12) . To investigate the differences between reports on the staging of prostate cancer, Engelbrecht et al. (12) conducted a meta-analysis of 146 studies, performed between January 1984 and May 2000. This study showed that MRI has a combined sensitivity and specificity of 71% in detecting extracapsular extension and seminal vesicle invasion. It also showed that the use of the spin echo sequence, an endorectal coil and multiple imaging planes improve staging performance (12) . Compared with pelvic phased array coils alone, MRI with an endorectal surface coil provides higher resolution images with a superior prostatic and periprostatic signal-to-noise ratio (13, 14) . Most prostate MRI examinations are performed using an air-filled endorectal coil that causes magnetic susceptibility gradients within the gland. Filling the endorectal coil with a perfluorocarbon (PFC) compound has been shown to improve the diagnostic quality of MRS (15) . Inflating the endorectal coil with a barium suspension may be an alternative to inflation with PFC in prostate MR studies, especially at high field strengths (such as 3 T) (16) .
Three Tesla scanners provide a better signal-to-noise ratio, allowing improved spatial and temporal resolution in prostate cancer imaging. Heijmink et al. (17) reported a significant improvement in image quality and staging performance with an endorectal coil compared to a body-array coil, using a 3 T MRI. A learning curve has also been described for local staging of prostate cancer, and MR staging performance improves with experience (11). predictive value (96%) (30) (31) (32) . With conventional MRI, the major criteria for lymph node metastasis assessment are the size and, to a lesser extent, the shape of the lymph node. Lymph nodes are considered to be malignant if the short axis diameter is elongated and larger than 10 mm in diameter or is round and larger than 8 mm in diameter (Fig. 4) (31) .
Diffusion-weighted MRI
DWI is based on the movement of water molecules within the intracellular and extracellular spaces. This movement causes a signal decay on b c d e a DWI due to the dephasing of protons between the two diffusion gradients (33) . When pathology causes an increase in tissue cellularity or cellular swelling, water motion becomes restricted and DWI shows high signal intensity in this area (34) . Apparent diffusion coefficient (ADC) maps provide a quantitative analysis of DWI by measuring the degree of diffusion. When the diffusion of water molecules is restricted, the ADC value decreases.
High b values (often 1000 s/mm 2 ) are commonly preferred in prostate MRI studies (35) . Diffusion tensor imaging (DTI) is a new emerging technique that is based on the calculation of anisotropic molecular diffusion of water molecules. DTI allows mapping of the microstructural fiber orientation of the tissue in three dimensions. Currently, DTI is more commonly used for investigating the normal prostatic structure and detecting prostate cancer. It has been reported that fiber tracking in the prostate may show the spread of cancer beyond the prostatic capsule (36) .
Extracapsular extension with DWI
DWI and ADC maps have not been used to predict extracapsular extension in prostate cancer because of distortions, artifacts, and poor spatial resolution. Recent technical advancements, such as echo planar imaging with fat suppression, can provide increased signal-to-noise ratios and spatial resolutions and may be used for the evaluation of extracapsular extension (Figs. 1 and 2).
Seminal vesicle invasion with DWI
Restricted diffusion is also expected when the seminal vesicles are invaded by prostate cancer cells (Fig. 3) , compared with normal seminal vesicles, which are mostly composed of seminal fluid with or without hemorrhage (37). Kim et al. (37) retrospectively evaluated the accuracy of combined T2-weighted MRI and DWI compared with T2-weighted MRI alone for predicting seminal vesicle invasion in patients with prostate cancer. This study was performed with a 3 T MRI, using a phased-array coil. The authors used ADC maps within the seminal vesicle without performing a quantitative analysis and reported that the use of T2-weighted MRI with DWI was more specific and accurate than that of T2-weighted MRI alone for the prediction of seminal vesicle invasion and noted that the addition of DWI to T2-weighted MRI showed significant improvement in diagnostic accuracy among less experienced readers. For the detection of seminal vesicle invasion in prostate cancer patients using 3 T MRI, T2-weighted images combined (41) , and moreover DWI is more superior to DCE MRI in the detection of prostate cancer (42) . Therefore, the routine use of DWI for seminal vesicle invasion requires validation.
Lymph node metastasis with DWI
DWI has also been evaluated in the analysis of pelvic lymph nodes. Eiber et al. (43) performed DWI of the pelvis at 1.5 T for investigating lymph node metastasis in patients with prostate cancer. The authors found a significant difference between the mean ADC value of malignant versus benign lymph nodes (43) . However, there is still substantial overlap between ADC values of benign and malignant lymph nodes, which precludes the clinical use of DWI for lymph node characterization. Additionally, diffusion-weighted whole-body MRI with background body signal suppression has the potential to detect metastatic lymph nodes (44, 45) .
DCE MRI
DCE MRI has emerged as a promising modality for prostate cancer imaging. The concept of DCE MRI is based on changes in the vascular characteristics of cancerous tissue compared with normal tissue. In cancerous tissue, angiogenesis (budding of new blood vessels), vasculogenesis (de novo formation of blood vessels), increased vascular permeability, and a larger interstitial space create a marked increase in the transfer rate of contrast material from the intravascular space to the extravascular/interstitial space. Time intensity curves and tracer kinetic models are used for extracting perfusion-related parameters from DCE MRI (Fig. 1)  (46-50) . Early, rapid, and strong enhancement with quick wash-out of contrast material is highly suggestive of prostate cancer in time-intensity curves (51, 52) . Tracer kinetic models describe the microscopic distribution of contrast agent between the vascular and extravascular spaces over time.
Various tracer kinetic models have been introduced by investigators. The 
Extracapsular extension with DCE MRI
Previous DCE MRI studies obtained high temporal resolution at the expense of spatial resolution. These techniques used thick sections and had lower accuracy rates for prostate cancer staging (24, 47) . Bloch et al. (54) reported that addition of high spatialresolution DCE MRI has improved the accuracy of T2-weighted MRI compared with T2-weighted MRI alone in the assessment of extracapsular extension (AUC 86% vs. 96%, respectively). In their study, color-coded schemes were obtained with a model that incorporated three time points from the DCE MRI. These images were analyzed for the presence of bright red extracapsular pixel clusters larger than 3 mm in diameter, which are considered to be suspicious for extracapsular extension (54). Fütterer et al. (55) fused parametric maps of DCE MRI with T2-weighted images in an attempt to differentiate The authors used the following DCE MRI parameters to evaluate the presence of extracapsular extension in prostate cancer: presence of high peak enhancement, asymmetric high peak enhancement, wash-out, and shorter onset time or increased time-to-peak. They reported that the addition of DCE MRI can significantly improve the interpretation of less experienced readers compared with T2-weighted MRI alone (AUC 66%, 82%, respectively), but that it made no additional contribution to experienced readers' staging performance (55) .
Seminal vesicle invasion with DCE MRI
The combination of peak enhancement with the presence of contrast material wash-out is highly suggestive of prostate cancer, both for peripheral and central cancers (47, 51) . Ogura et al. (56) interpreted early enhancement in the seminal vesicles on dynamic T1-weighted images as seminal vesicle invasion and reported that this finding has accuracy rates as high as 97% for seminal vesicle invasion. Fütterer et al. (55) found that the addition of contrast-enhanced MRI only benefited less experienced readers in terms of determining whether seminal vesicle invasion and extracapsular extension were present.
Lymph node metastasis with DCE MRI
To our knowledge, no studies have evaluated the ability of DCE MRI to diagnose lymph node metastasis from prostate cancer. Another novel technique, MR lymphography, has been introduced recently. MR lymphography uses intravenously administered ferumoxtran-10, which belongs to a class of nanoparticle-based contrast agents that are referred to as ultrasmall superparamagnetic iron oxide. Harisinghani et al. (57) reported high sensitivity (100%) and specificity (95.7%) values in a study investigating lymph node metastasis of the prostate cancer with this technique. A clear advantage of MR lymphography is that it is able to detect small metastatic lymph nodes. Although these agents were recently pulled from the market and are not currently available, clinical trials are continuing with a derivative of ferumoxtran-10, ferumoxytol, for the detection of lymph node involvement in prostate cancer.
MRS
MRS is based on the chemical shift resulting from the shield formed by the electron cloud surrounding hydrogen nuclei in molecules (58) . MRS identifies metabolites of interest in prostate tissue by locating the peaks of chemical compounds. In prostate cancer, increases in the choline and creatine peaks and a decrease in the citrate peak are expected findings (Fig. 5) . MRS requires a very homogeneous magnetic field (shimming). Advanced operating skills are also needed for post-processing of the prostatic spectra to achieve high-quality data, so the process has a relatively long post-processing time. Post-biopsy hemorrhage lowers the sensitivity of MRS by degrading the MR spectra (59) .
MRS has a high specificity for prostate cancer detection, but it has a low sensitivity because of partial volume effects and strong signals from the surrounding tissue, especially the seminal vesicles, stromal benign prostatic hyperplasia and prostatitis (60) .
Local staging with MRS
Studies that investigated MRS as a method of detecting extracapsular extension in patients with prostate cancer are somewhat controversial. It has been reported that using MRS with conventional MRI may improve overall staging by identifying foci of extracapsular disease (10). Yu et al. (61) reported that the addition of three-dimensional (3D) MRS imaging to MRI improved the diagnostic accuracy for extracapsular extension only among less experienced readers. These authors used the location and number of abnormal MRS voxels as the primary MRS imaging data for the evaluation of extracapsular extension (61) . In their study, patients with the least extensive tumors on 3D MRS (<1 cancer voxel per section) were found to have only a 6% risk for extracapsular extension, whereas patients with the most extensive tumors (>4 cancer voxels per section) had an 80% risk of extracapsular extension (61) . The authors therefore claimed that 3D MRS has potential as a predictor of extracapsular extension (61) . Because the resolution of MRS is lower than that of conventional MRI, MRS may not depict small foci of extracapsular spread. Wetter et al. (62) showed that there is no significant improvement in detecting extracapsular extension in patients with prostate cancer when using MRI vs. MRS. MRS is therefore not recommended for use in the routine staging of prostate carcinoma (62) .
MRS does not play a role in the assessment of the probability of seminal vesicle invasion. No comprehensive study in the literature has used MRS to detect lymph node involvement in prostate cancer. However, Heijmink et al. (63) reported high choline levels in an enlarged metastatic lymph node in a patient with recurrent prostate cancer. They claimed that it was possible to use MRS with a 3 T MRI to quantify the total amount of choline-containing compounds in lymph node metastases located deep inside the body (63) .
Conclusion
Accurate local staging of prostate cancer is essential for the management of this disease. T2-weighted scans are still the main MRI sequence for local staging in prostate cancer. DWI, DCE MRI, and MRS are available but evolving techniques and can be considered as a part of a multi-modality MRI protocol for imaging of the prostate gland. To interpret these studies accurately, radiologists should be aware of the advantages, limitations, and technical background of these functional techniques. There is still a need for multi-institutional trials to standardize functional MRI techniques and interpretation criteria.
